These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 2946953)
1. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953 [TBL] [Abstract][Full Text] [Related]
2. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells. Karlsson FA; Tötterman TH Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281 [TBL] [Abstract][Full Text] [Related]
3. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575 [TBL] [Abstract][Full Text] [Related]
4. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism. Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555 [TBL] [Abstract][Full Text] [Related]
5. Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission. Peakman M; Hussain M; Cundy T; Vergani D J Clin Lab Immunol; 1989 Sep; 30(1):1-5. PubMed ID: 2577115 [TBL] [Abstract][Full Text] [Related]
6. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease. Charreire J; Karsenty G; Bouchard P; Schaison G Clin Exp Immunol; 1984 Sep; 57(3):633-8. PubMed ID: 6147216 [TBL] [Abstract][Full Text] [Related]
7. Analysis of peripheral T lymphocyte subpopulations in Graves' disease. Okabe N; Inoue K; Mori R J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106 [TBL] [Abstract][Full Text] [Related]
8. Carbimazole and the autoimmune response in Graves' disease. McGregor AM; Petersen MM; McLachlan SM; Rooke P; Smith BR; Hall R N Engl J Med; 1980 Aug; 303(6):302-7. PubMed ID: 6247656 [TBL] [Abstract][Full Text] [Related]
10. Methimazole treatment in Graves' disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets. Paggi A; Amoroso A; Ferri GM; Mariotti A; Pellegrino C; Afeltra A Eur Rev Med Pharmacol Sci; 1998; 2(1):11-9. PubMed ID: 9825565 [TBL] [Abstract][Full Text] [Related]
11. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission. Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661 [TBL] [Abstract][Full Text] [Related]
12. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease. Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751 [TBL] [Abstract][Full Text] [Related]
13. Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease. Aust G; Lehmann I; Heberling HJ Exp Clin Endocrinol Diabetes; 1996; 104(1):50-8. PubMed ID: 8750571 [TBL] [Abstract][Full Text] [Related]
14. The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease. Eguchi K; Otsubo T; Kawabe Y; Ueki Y; Fukuda T; Matsunaga M; Shimomura C; Ishikawa N; Tezuka H; Nakao H Clin Exp Immunol; 1987 Nov; 70(2):403-10. PubMed ID: 2962792 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose. Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice. Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581 [TBL] [Abstract][Full Text] [Related]
17. Characterization of lymphoid cells in the thyroid of patients with Graves' disease. Warford A; McLachlan SM; Malcolm AJ; Young ET; Farndon JR; Rees Smith B Clin Exp Immunol; 1984 Sep; 57(3):626-32. PubMed ID: 6235996 [TBL] [Abstract][Full Text] [Related]
18. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease. O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945 [TBL] [Abstract][Full Text] [Related]
19. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production. Iwatani Y; Iitaka M; Row VV; Volpé R Clin Invest Med; 1988 Aug; 11(4):279-85. PubMed ID: 3262474 [TBL] [Abstract][Full Text] [Related]
20. Anti-thyroid drugs and lymphocyte function. II. The in vivo effect on blastogenesis and suppressor cell activity in Graves' disease. Goldrath N; Shoham J; Bank H; Eisenstein Z Clin Exp Immunol; 1982 Oct; 50(1):62-9. PubMed ID: 6217001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]